StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
229
This month
2
This week
1
This year
34
Publishing Date
2024 - 03 - 13
2
2024 - 03 - 05
2
2024 - 02 - 28
2
2024 - 02 - 01
2
2024 - 01 - 17
2
2024 - 01 - 12
2
2023 - 12 - 14
3
2023 - 11 - 03
2
2023 - 11 - 01
2
2023 - 09 - 29
2
2023 - 09 - 22
2
2023 - 08 - 28
2
2023 - 08 - 25
5
2023 - 08 - 22
2
2023 - 07 - 21
2
2023 - 07 - 05
2
2023 - 06 - 29
2
2023 - 06 - 23
2
2023 - 06 - 08
2
2023 - 05 - 17
2
2023 - 04 - 25
2
2023 - 03 - 20
2
2023 - 03 - 15
2
2023 - 02 - 24
3
2023 - 02 - 20
2
2023 - 02 - 17
3
2023 - 02 - 16
2
2023 - 02 - 13
2
2023 - 01 - 26
2
2023 - 01 - 25
2
2023 - 01 - 16
3
2023 - 01 - 03
2
2022 - 12 - 30
3
2022 - 12 - 01
2
2022 - 11 - 21
2
2022 - 09 - 28
2
2022 - 09 - 20
1
2022 - 09 - 19
2
2022 - 09 - 16
2
2022 - 09 - 14
1
2022 - 09 - 13
2
2022 - 09 - 09
1
2022 - 09 - 08
1
2022 - 09 - 05
2
2022 - 09 - 02
1
2022 - 08 - 29
1
2022 - 08 - 26
1
2022 - 08 - 25
1
2022 - 08 - 23
1
2022 - 08 - 22
1
2022 - 08 - 19
1
2022 - 08 - 16
1
2022 - 08 - 12
1
2022 - 08 - 10
1
2022 - 08 - 08
1
2022 - 08 - 03
2
2022 - 08 - 02
1
2022 - 07 - 25
2
2022 - 07 - 21
1
2022 - 07 - 19
1
Sector
Commercial services
1
Consumer non-durables
5
Consumer services
1
Distribution services
1
Electronic technology
5
Finance
1
Health services
3
Health technology
229
Information
1
Manufacturing
25
N/a
15
Process industries
5
Producer manufacturing
8
Professional, scientific, and technical services
2
Technology services
3
Tags
America
67
Antibody
13
Application
12
Approval
21
Biosimilar
39
Breast
13
Cancer
106
Covid
17
Covid-19
12
Device
14
Diabetes
18
Diagnostics
19
Disease
76
Drug
115
Drug delivery
11
Earnings
21
Europe
17
Expansion
11
Expected
35
Eye
21
Fda
28
Financial
24
Financial results
13
Gene therapy
11
Global
229
Growing
47
Growth
262
Health
19
Immunotherapy
12
Kisqali
11
Leukemia
12
Liver
20
Market
599
N/a
1115
Novartis
133
Patent
13
People
20
Pharma
17
Pharmaceuticals
17
Pipeline
12
Positive
19
Potential
13
Reach
34
Report
195
Research
129
Respiratory
15
Results
52
Risk
11
Sales
11
Sclerosis
13
Set
16
Study
17
T-cell
12
Technology
14
Therapeutics
114
Therapy
89
Treatment
137
Trial
25
Vaccine
16
Year
12
Entities
3m company
215
Abb ltd
209
Abbott laboratories
349
Abbvie inc.
113
Accenture plc
72
Agilent technologies, inc.
88
Alphabet inc.
91
Amgen inc.
83
Apple inc.
138
Arcelormittal
64
Arrival
146
Astrazeneca plc
108
Beam global
123
Becton, dickinson and company
159
Bio-rad laboratories, inc.
110
Boston scientific corporation
116
Bristol-myers squibb company
67
Cisco systems, inc.
134
Cummins inc.
73
Danaher corporation
163
Deere & company
69
Denso corp
113
Dupont de nemours, inc.
86
Eastman chemical company
79
Eli lilly and company
149
Ericsson
183
Exxon mobil corporation
76
Ford motor company
75
General electric company
197
Glaxosmithkline plc
159
Global industrial co
67
Honeywell international inc.
287
Illumina, inc.
70
Infineon technologies ag
100
Intel corporation
184
International business machines corporation
97
Johnson & johnson
422
Koninklijke philips n.v.
200
Linde plc
66
Lockheed martin corporation
147
Medtronic plc
223
Microsoft corporation
258
Morgan stanley
246
Nec corp
109
Northrop grumman corporation
112
Novartis ag
229
Nvidia corporation
90
Oracle corporation
207
Orange
218
Panasonic corp
184
Qiagen n.v.
77
Raytheon technologies corporation
70
S&p global inc.
149
Sanofi
356
Sap se
172
Stryker corporation
100
Terumo corp
82
Teva pharmaceutical industries ltd
111
Thermo fisher scientific inc
281
Zte corp
69
Symbols
A
2
ABBV
50
ABT
35
ADAP
3
AERI
2
ALB
2
ALKS
2
ALPMF
11
ALPMY
11
AMGN
41
AUTL
2
AZN
44
AZNCF
44
BAX
5
BDX
5
BHC
14
BIIB
9
BIO
3
BMY
34
BNTX
3
BRKR
2
BSX
3
CMXHF
4
CSLLY
4
DHR
7
DTIL
3
ENDP
7
ENDPQ
7
GE
3
GILD
15
GLAXF
70
GMAB
2
GSK
70
ILMN
4
JNJ
82
LLY
50
MDT
6
MMM
5
MNK
3
MNKKQ
3
MNKPF
3
NVO
15
NVS
229
NVSEF
228
OPK
3
PFE
21
PHG
5
RBGLY
3
RBGPF
3
REGN
5
SNY
81
SNYNF
81
TAK
15
TEVJF
44
TMO
13
TRUMF
5
TRUMY
5
UCBJF
3
UCBJY
3
VTRS
18
Exchanges
Nasdaq
229
Nyse
229
Crawled Date
2024 - 03 - 13
2
2024 - 03 - 05
2
2024 - 02 - 28
2
2024 - 02 - 01
2
2024 - 01 - 17
2
2024 - 01 - 12
2
2023 - 12 - 14
2
2023 - 11 - 03
2
2023 - 11 - 01
2
2023 - 09 - 29
2
2023 - 09 - 22
2
2023 - 08 - 28
2
2023 - 08 - 25
5
2023 - 08 - 22
2
2023 - 07 - 21
2
2023 - 06 - 29
2
2023 - 06 - 23
2
2023 - 06 - 08
2
2023 - 04 - 28
2
2023 - 04 - 25
2
2023 - 03 - 15
2
2023 - 02 - 24
3
2023 - 02 - 21
2
2023 - 02 - 17
3
2023 - 02 - 16
2
2023 - 02 - 14
2
2023 - 01 - 27
2
2023 - 01 - 25
2
2023 - 01 - 16
3
2023 - 01 - 03
2
2022 - 12 - 30
3
2022 - 12 - 01
2
2022 - 11 - 21
2
2022 - 09 - 28
2
2022 - 09 - 23
1
2022 - 09 - 22
1
2022 - 09 - 20
1
2022 - 09 - 19
2
2022 - 09 - 16
2
2022 - 09 - 14
1
2022 - 09 - 13
2
2022 - 09 - 09
1
2022 - 09 - 08
1
2022 - 09 - 05
2
2022 - 09 - 02
1
2022 - 08 - 29
1
2022 - 08 - 26
1
2022 - 08 - 25
1
2022 - 08 - 23
1
2022 - 08 - 22
1
2022 - 08 - 19
1
2022 - 08 - 16
1
2022 - 08 - 12
1
2022 - 08 - 10
1
2022 - 08 - 08
1
2022 - 08 - 03
2
2022 - 08 - 02
1
2022 - 07 - 25
2
2022 - 07 - 21
1
2022 - 07 - 19
1
Crawled Time
00:00
14
00:20
3
01:00
15
02:00
8
03:00
5
04:00
2
04:20
4
05:00
1
06:00
2
09:00
4
10:00
8
11:00
12
11:01
1
12:00
7
12:20
1
13:00
4
14:00
4
14:20
1
14:30
1
14:49
1
15:00
8
15:20
3
15:30
5
16:00
14
16:20
1
17:00
20
18:00
16
19:00
14
20:00
15
21:00
10
22:00
14
23:00
11
Source
www.globenewswire.com
4
www.prnewswire.com
225
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Global
entities :
Novartis ag
save search
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published:
2024-04-17
(Crawled : 10:00)
- prnewswire.com
TMO
|
News
|
$543.895
0.44%
830K
|
Health Technology
|
-4.36%
|
O:
-0.26%
H:
0.03%
C:
-1.55%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
0.28%
|
O:
0.87%
H:
0.16%
C:
-0.59%
RGNX
|
$15.49
-3.85%
210K
|
Health Technology
|
-4.57%
|
O:
-1.43%
H:
2.27%
C:
-3.18%
global
dna
market
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-1.57%
|
O:
0.32%
H:
0.04%
C:
-0.56%
ARVN
|
$34.02
-0.79%
250K
|
Health Technology
|
-7.45%
|
O:
8.28%
H:
0.56%
C:
-4.75%
arv-766
protac
license
cancer
treatment
global
protein
for
commercialization
agreement
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.89
1.22%
5.1M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
News
|
$66.45
0.44%
4.3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$267.41
1.77%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.68
1.23%
150K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$290.38
220
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$165.97
0.8%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-7.14%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
$39.585
0.8%
1.1M
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-3.52%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$48.89
1.22%
5.1M
|
Health Technology
|
-9.3%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
$267.41
1.77%
1.4M
|
Health Technology
|
-7.46%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness
Published:
2024-03-21
(Crawled : 00:00)
- prnewswire.com
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-3.12%
|
O:
0.17%
H:
0.28%
C:
-0.01%
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-6.81%
|
O:
0.02%
H:
0.0%
C:
0.0%
BHC
|
$8.63
0.35%
1.5M
|
Health Technology
|
-8.0%
|
O:
-0.74%
H:
1.54%
C:
1.38%
ABBV
|
News
|
$165.97
0.8%
3.1M
|
Health Technology
|
-6.49%
|
O:
0.16%
H:
0.0%
C:
0.0%
report
expansion
global
wellness
smart
growing
eye
market
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published:
2024-03-13
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-6.71%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-10.2%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-0.55%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
News
|
$165.97
0.8%
3.1M
|
Health Technology
|
-8.97%
|
O:
0.59%
H:
0.01%
C:
-1.45%
drug
disease
report
research
global
market
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published:
2024-03-13
(Crawled : 01:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-6.71%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-10.2%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-0.55%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
News
|
$165.97
0.8%
3.1M
|
Health Technology
|
-8.97%
|
O:
0.59%
H:
0.01%
C:
-1.45%
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
-5.85%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
research
global
Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published:
2024-03-07
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
$138.24
800
|
Health Technology
|
4.68%
|
O:
3.21%
H:
0.0%
C:
-1.71%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-6.85%
|
O:
0.08%
H:
0.86%
C:
0.7%
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-9.42%
|
O:
-0.68%
H:
0.0%
C:
0.0%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-3.77%
|
O:
-0.02%
H:
0.0%
C:
-2.29%
ABT
|
News
|
$106.76
1.42%
3.8M
|
Health Technology
|
-11.4%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
-5.38%
|
O:
-0.08%
H:
0.0%
C:
0.0%
AZN
|
$68.41
0.07%
2.9M
|
Health Technology
|
3.13%
|
O:
-0.03%
H:
0.62%
C:
0.5%
AMGN
|
$267.41
1.77%
1.4M
|
Health Technology
|
-2.9%
|
O:
-0.02%
H:
1.37%
C:
0.34%
company
report
global
market
Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published:
2024-03-05
(Crawled : 05:00)
- prnewswire.com
TMO
|
News
|
$543.895
0.44%
830K
|
Health Technology
|
-8.36%
|
O:
-0.09%
H:
0.86%
C:
0.6%
DGX
|
$128.08
1.72%
770K
|
Health Services
|
1.68%
|
O:
0.38%
H:
0.69%
C:
-1.01%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-8.72%
|
O:
0.32%
H:
0.22%
C:
-0.2%
BIO
|
News
|
$277.33
-1.31%
110K
|
Health Technology
|
-18.49%
|
O:
-0.53%
H:
1.08%
C:
-0.59%
ABT
|
News
|
$106.76
1.42%
3.8M
|
Health Technology
|
-10.22%
|
O:
1.6%
H:
0.0%
C:
0.0%
QDEL
M
|
$38.795
1.4%
610K
|
Health Technology
|
-12.68%
|
O:
0.18%
H:
1.13%
C:
-3.31%
report
respiratory
global
rsv
virus
diagnostics
growth
market
Janus Kinase (JAK) Inhibitors Global Market Report 2024, Featuring Key Players Pfizer, Merck, AbbVie, Novartis, Sanofi, Bristol Myers Squibb, GSK, Takeda, Eli Lilly and Gilead Sciences
Published:
2024-03-05
(Crawled : 01:00)
- prnewswire.com
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-8.72%
|
O:
0.32%
H:
0.22%
C:
-0.2%
ABBV
|
News
|
$165.97
0.8%
3.1M
|
Health Technology
|
-7.56%
|
O:
-0.24%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
-3.17%
|
O:
1.17%
H:
0.0%
C:
0.0%
report
sciences
global
key
market
Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published:
2024-02-28
(Crawled : 11:00)
- prnewswire.com
ROIV
|
$10.305
-0.53%
1.7M
|
Manufacturing
|
-11.53%
|
O:
-0.76%
H:
0.51%
C:
0.0%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-9.76%
|
O:
0.05%
H:
0.06%
C:
-0.95%
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-9.41%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$165.97
0.8%
3.1M
|
Health Technology
|
-7.61%
|
O:
0.6%
H:
0.02%
C:
-1.03%
global
set
dermatological
advanced
growth
market
Global Antibiotic Drugs Market Report 2024-2029: A $50.41 Billion Industry in 2022 - Focus on United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India
Published:
2024-02-28
(Crawled : 03:00)
- prnewswire.com
VTRS
|
$11.21
0.81%
2.4M
|
Health Technology
|
-15.95%
|
O:
-0.15%
H:
2.57%
C:
-6.96%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-9.76%
|
O:
0.05%
H:
0.06%
C:
-0.95%
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-9.41%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABT
|
News
|
$106.76
1.42%
3.8M
|
Health Technology
|
-9.96%
|
O:
1.12%
H:
0.52%
C:
0.47%
report
india
global
market
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published:
2024-02-23
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.97%
|
O:
0.37%
H:
0.58%
C:
0.58%
VTRS
|
$11.21
0.81%
2.4M
|
Health Technology
|
-16.77%
|
O:
0.0%
H:
1.93%
C:
1.27%
NVO
|
$122.69
-0.05%
3.8M
|
Health Technology
|
0.01%
|
O:
-0.68%
H:
0.4%
C:
-0.18%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-9.46%
|
O:
0.89%
H:
0.4%
C:
0.17%
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-9.66%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
-5.02%
|
O:
0.97%
H:
0.0%
C:
0.0%
report
revenue
global
insulin
growth
market
Global Incretin Based Drugs Research Report 2023: Market to Reach $64.28 Billion by 2029 from $40 Billion in 2022, Driven by Increasing Prevalence of Diabetes
Published:
2024-02-21
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
$138.24
800
|
Health Technology
|
5.3%
|
O:
-0.88%
H:
1.75%
C:
-0.29%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-9.38%
|
O:
-0.65%
H:
0.62%
C:
0.5%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
-0.65%
|
O:
-2.33%
H:
1.55%
C:
1.06%
AZN
|
$68.41
0.07%
2.9M
|
Health Technology
|
4.96%
|
O:
-1.01%
H:
1.1%
C:
1.1%
report
reach
research
global
diabetes
market
Biosimilar Lymphocyte Modulator Global Market Report 2024 - Robust 10.6% CAGR Forecast, Amid Rising Autoimmune Disease Prevalence
Published:
2024-02-20
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-6.46%
|
O:
2.81%
H:
0.0%
C:
-0.95%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-7.1%
|
O:
2.91%
H:
0.35%
C:
-0.38%
BIIB
|
$192.68
1.13%
590K
|
Health Technology
|
-10.92%
|
O:
-0.69%
H:
1.24%
C:
0.76%
disease
biosimilar
report
global
market
9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published:
2024-02-19
(Crawled : 16:00)
- prnewswire.com
BIIB
|
$192.68
1.13%
590K
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$11.21
0.81%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.41
0.07%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
510
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.585
0.8%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$138.24
800
|
Health Technology
|
Email alert
Add to watchlist
JAZZ
|
$110.6
1.22%
210K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$267.41
1.77%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
cancer
cell
global
growth
market
Global Intraocular Lens Market Report 2024: Market to Grow from $4.23 Billion in 2023 to $6.11 Billion by 2030 - Rising Incidence of Myopia and Diabetes Boosts Demand
Published:
2024-02-16
(Crawled : 23:00)
- prnewswire.com
BHC
|
$8.63
0.35%
1.5M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$79.43
1.22%
760K
|
Health Technology
|
Email alert
Add to watchlist
STAA
|
$46.205
-1.21%
210K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
report
global
diabetes
market
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published:
2024-02-15
(Crawled : 23:00)
- prnewswire.com
TRUMF
|
$16.928
1.9K
|
Health Technology
|
-53.57%
|
O:
0.79%
H:
0.0%
C:
-3.21%
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
0.42%
|
O:
1.66%
H:
0.0%
C:
-1.59%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-5.89%
|
O:
1.66%
H:
0.0%
C:
-1.04%
TRUMY
|
$16.507
34K
|
Manufacturing
|
-55.13%
|
O:
0.27%
H:
0.0%
C:
-2.6%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-6.57%
|
O:
0.37%
H:
0.57%
C:
0.19%
JNJ
|
News
|
$147.17
0.98%
3.2M
|
Health Technology
|
-8.21%
|
O:
-0.83%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$165.97
0.8%
3.1M
|
Health Technology
|
-6.47%
|
O:
0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
-2.15%
|
O:
-0.6%
H:
0.0%
C:
0.0%
drug
patent
report
review
global
advanced
market
Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances
Published:
2024-02-14
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.06%
|
O:
1.95%
H:
0.0%
C:
0.0%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-6.03%
|
O:
0.26%
H:
0.87%
C:
0.32%
ABBV
|
News
|
$165.97
0.8%
3.1M
|
Health Technology
|
-4.64%
|
O:
0.48%
H:
1.56%
C:
1.48%
AMGN
|
$267.41
1.77%
1.4M
|
Health Technology
|
-8.67%
|
O:
-0.75%
H:
0.86%
C:
0.41%
biosimilar
report
global
therapy
growth
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
$138.24
800
|
Health Technology
|
9.56%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
$94.285
1.85%
1.6M
|
Health Technology
|
-7.87%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
$727.48
-2.48%
2M
|
Health Technology
|
1.43%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$48.89
1.22%
5.1M
|
Health Technology
|
-3.03%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
News
|
$165.97
0.8%
3.1M
|
Health Technology
|
-5.62%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$106.76
1.42%
3.8M
|
Health Technology
|
-5.21%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.545
2.55%
2.3M
|
Health Technology
|
-2.34%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
$68.41
0.07%
2.9M
|
Health Technology
|
9.65%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
$267.41
1.77%
1.4M
|
Health Technology
|
-8.99%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
← Previous
1
2
3
4
5
6
7
8
9
10
11
12
Next →
Gainers vs Losers
71%
29%
Top 10 Gainers
AGBA
|
News
|
$1.27
217.5%
120M
|
Finance
EGOX
|
$0.0503
39.72%
320M
|
RWOD
|
$10.52
31.56%
5.9M
|
n/a
ZCMD
|
$1.905
31.38%
30M
|
Commercial Services
MRDB
4
|
$0.536
27.65%
2M
|
n/a
BSFC
|
$0.0822
27.64%
75M
|
Manufacturing
TPET
|
$0.4121
25.68%
45M
|
n/a
NVFY
|
$2.65
25.59%
33M
|
Consumer Durables
INDO
|
$5.1
25.0%
15M
|
Energy Minerals
CHRO
|
$1.53
24.9%
100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.